Burloza, Maria Kezia .

HRN: 21-74-12  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2022
CEFUROXIME 750MG (VIAL)
08/02/2022
08/08/2022
IVT
250mg
Q8
Uti

 Indication:  Prophylaxis    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines